Scientific Advisory Board2018-10-10T17:24:58+00:00

Scientific Advisory Board

Our scientific advisors are visionary leaders and innovators across multiple areas of genomic medicine.

Chair of the Genome Medical Scientific Advisory Board. He is Professor of Medicine at Harvard Medical School, and directs the Genomes2People Research Program in translational genomics at Brigham and Women’s Hospital and Broad Institute. He conducts empirical research on the medical, behavioral and economic outcomes around the implementation of genomic medicine. Dr. Green is directing some of the first trials to explore sequencing in adults (the MedSeq Project) newborn infants (the BabySeq Project) and active duty military personnel (the MilSeq Project).

Robert Green, MD, MPH
Chair

Associate professor of Medicine, Genetics and Biomedical Data Science at Stanford and director of the Center for Inherited Cardiovascular Disease, co-director of the Clinical Genomics service, and co-director of the Stanford Data Science Initiative. In 2010, he led the team that carried out the first clinical interpretation of a human genome.

Euan Ashley FRCP, DPHIL

Director of the Metabolism Program at Children’s Hospital Boston, professor of Pediatrics at Harvard Medical School, and director of Harvard’s Biochemical Genetics Training Program. A leader in metabolic genetics, he is 2019 president-elect of the Society of Inherited Metabolic Disorders.

Gerard T. Berry MD

Associate director of the Division of Human Genetics and associate director of biospecimen research at The Ohio State University Comprehensive Cancer Center and former president of the American Board of Genetic Counseling. Ms. Hampel is an internationally recognized cancer genetic counselor whose research has led to changes in standard-of-care genetic screening practices for colon cancer.

Heather Hampel MS, LCGC

Chair of the Department of Genetics and Director of the Heflin Center for Genomic Sciences at the University of Alabama at Birmingham. He is current president of the American College of Medical Genetics and Genomics Foundation for Genetic and Genomic Medicine and has held leadership roles in most of the major genetics professional societies. In addition, Dr. Korf is at the forefront of developing novel approaches for integrating genetics and genomics into medical practice.

Bruce R. Korf MD, PHD

Chief medical officer of Invitae. He is the former chief of the University of California, San Francisco’s Division of Genomic Medicine and medical director of the Cancer Risk Program and the UCSF Program in Cardiovascular Genetics. He is also the former chief of the Genetic Diseases Research and Inherited Disease Research Branches of the National Human Genome Research Institute and former president of the American Society of Human Genetics.

Robert L. Nussbaum MD

Director of the Partners Healthcare Laboratory for Molecular Medicine, medical director of the Broad Institute’s Clinical Research Sequencing Platform, and associate professor of pathology at Brigham and Women’s Hospital and Harvard Medical School. Through her leadership roles in the NIH-funded Clinical Genome Resource program and the international Global Alliance for Genomics and Health as well as committee roles in the American College of Medical Genetics and Genomics she has been instrumental in developing standards and resources to support data sharing, genomic sequencing and the interpretation of genetic variation.

Heidi L. Rehm PhD, FACMG

Associate professor and Vernice D. Ferguson Chair in Health Equity, Rory Meyers College of Nursing, New York University. Her work examines genomic and social factors contributing to health disparities for chronic conditions in underrepresented populations. In 2017, she was awarded the Presidential Early Career Award for Scientists and Engineers by President Obama.

Jacquelyn Taylor, PhD, RN

President and CEO of Genetic Alliance and cofounder of the Genetic Alliance Registry and Biobank. She is also the founding CEO of PXE International. She is co-PI of PCORnet’s Coordinating Center and the co-chair of the National Academy of Medicine Genomics and Health Roundtable. She led the coalition instrumental in passing the Genetic Information Nondiscrimination Act. She is a citizen scientist and advocate.

Sharon F. Terry MA

Pediatric and cardiovascular genetic counselor, University of Virginia Health System. From 2014-2017 he was chair of Virginia’s Advisory Board of Genetic Counselors. In 2013, he founded the first cardiovascular genetics program in the state.

Matthew J. Thomas, ScM, CGC

Assistant professor of medicine at Harvard Medical School, clinician at Dana-Farber/Partners Cancer Care, and associate member at the Broad Institute of MIT and Harvard. He is a computational biologist and medical oncologist; his research focuses on computational cancer genomics and applying new technologies to precision cancer medicine.

Eliezer Van Allen MD

Director of the Graduate Program in Genetic Counseling at Northwestern University and associate professor in the Department of Obstetrics and Gynecology. She is past president of the National Society of Genetic Counselors (NSGC) and NSGCs’ representative on the National Academies of Sciences, Engineering, Medicine Roundtable on Genomics and Precision Health. Ms. Wicklund’s expertise is in genetic counseling and genomic education and her research interests include bringing personalized medicine into broader clinical use.

Catherine A. Wicklund MS, CGC
Genome Medical